NT-proBNP in patients presenting with myocardial infarction and non-obstructive coronary arteries without left ventricular systolic dysfunction.

Journal: American heart journal plus : cardiology research and practice
Published Date: Jul 27, 2023

Abstract

BACKGROUND: Myocardial infarction and non-obstructive coronary arteries (MINOCA) affects 1 in 9 patients with acute coronary syndrome and has no evidence-based therapy. NT-proBNP is an established biomarker associated with prognosis in heart failure and ischemic heart disease, although there is a paucity of data in patients with MINOCA.

Authors

  • Robert Sykes
    School of Cardiovascular and Metabolic Health, University of Glasgow, G12 8TA, UK.
  • Daniel Doherty
    West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Glasgow, UK.
  • Andrew Morrow
    School of Cardiovascular and Metabolic Health, University of Glasgow, G12 8TA, UK.
  • Kenneth Mangion
    School of Cardiovascular and Metabolic Health, University of Glasgow, G12 8TA, UK.
  • Ahsan Rushd
    School of Cardiovascular and Metabolic Health, University of Glasgow, G12 8TA, UK.
  • Colin Berry
    School of Cardiovascular and Metabolic Health, University of Glasgow, G12 8TA, UK.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals